{"id":"W2151082560","doi":"10.1093/annonc/mdu456","title":"Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2","year":2014,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":568,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital du Saint-Sacrement; Sunnybrook Health Science Centre; University of Toronto","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Exemestane; Human Epidermal Growth Factor Receptor 2; Everolimus; Oncology; Internal medicine; Hormone receptor; Breast cancer; Cancer research; Cancer; Aromatase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001114909,0.0008199129,0.00125456,0.0005114802,0.0003321375,0.0008786019,0.0004566893,0.0004892861,0.002278634],"category_scores_gemma":[0.0005893857,0.0002462444,0.002084616,0.0004797841,0.0004807191,0.0006422707,0.0003968439,0.001623077,0.0004633077],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009757594,"about_ca_system_score_gemma":0.0008497904,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002263409,"about_ca_topic_score_gemma":0.006393326,"domain_scores_codex":[0.9996392,0.0001239425,0.00003023334,0.00007561389,0.0000553781,0.00007554758],"domain_scores_gemma":[0.9995957,0.00007818457,0.00009187231,0.00005290566,0.00002463784,0.0001566424],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6833244,0.02468771,0.03184944,0.001230131,0.006510664,0.000339854,0.0003838049,0.003051577,0.0220637,0.0003246206,0.00338353,0.2228505],"study_design_scores_gemma":[0.2550368,0.4378955,0.2595462,0.0004601637,0.01441247,0.001450017,0.0004152117,0.001826901,0.008699222,0.0005219509,0.01960477,0.0001306745],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9851599,0.009374671,0.0001340785,0.0002776054,0.00009845876,0.000136065,0.001514577,0.00002554212,0.00327916],"genre_scores_gemma":[0.973679,0.01272624,0.0007385812,0.0009251611,0.0003138,0.0001860284,0.006082972,0.00004396963,0.005304283],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002278634,"threshold_uncertainty_score":0.007622778,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0499435101726918,"score_gpt":0.3632289122475997,"score_spread":0.313285402074908,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}